Skip to main content

View full-text article in PMC

. 2022 Oct 10;27(19):6763. doi: 10.3390/molecules27196763

Table 51.

Antidiabetic potential of the compounds (ad50–ad51) according to α-amylase inhibitory activity.

Comp.	% Inhibition				IC₅₀ (µg/mL)
Comp.	25 µg/mL	50 µg/mL	75 µg/mL	100 µg/mL	IC₅₀ (µg/mL)
ad50	32.59	51.78	66.98	81.30	22.35
ad51	27.77	53.23	62.27	79.43	27.63
Acarbose	37.35	53.45	73.25	88.57	21.44